Cost-effectiveness of a peer mentoring intervention to improve disease self-management practices and self-efficacy among African American women with systemic lupus erythematosus: analysis of the Peer Approaches to Lupus Self-management (PALS) pilot study
Restricted accessResearch articleFirst published online July, 2019
Cost-effectiveness of a peer mentoring intervention to improve disease self-management practices and self-efficacy among African American women with systemic lupus erythematosus: analysis of the Peer Approaches to Lupus Self-management (PALS) pilot study
The Peer Approaches to Lupus Self-management (PALS) program was developed as a peer mentoring tool to improve health behaviors, beliefs, and outcomes in African American women with systemic lupus erythematosus (SLE). This study aims to assess the cost of the PALS intervention and determine its effectiveness when compared to existing treatments.
Methods
Peer mentors and mentees were paired on shared criteria such as life stage, marital status, or whether they were mothers. This 12-week program consisted of a weekly peer mentoring session by telephone. Cost of healthcare utilization was evaluated by assessing the healthcare costs pre- and post-intervention. Validated measures of quality of life, self-management, disease activity, depression, and anxiety were collected. Total direct program costs per participant were totaled and used to determine average per unit improvement in outcome measures. The benefit-cost ratio and pre- versus post-intervention hospital charges were examined.
Results
A total of 20 mentees and 7 mentors were enrolled in the PALS program. All PALS pairs completed 12 sessions lasting an average of 54 minutes. Mentees reported statistically significant decreases in patient-reported disease activity, depression, and anxiety, with improved trends in patient activation or patient engagement in their disease and management. The total cost per patient was $1291.50, which was $107.62 per patient per week. There was a savings of $23,417 per individual receiving the intervention with a benefit-cost ratio of 18.13 per patient.
Conclusion
These findings suggest that the PALS intervention was effective in improving patient-level factors and was cost-effective. Future research will need to validate these findings in a larger sample.
KanHSongXJohnsonBBechtelBO'SullivanDMoltaC. Healthcare utilization and costs of systemic lupus erythematosus in Medicaid. Biomed Res Int2013, pp. 2013.
2.
NarayananSWilsonKOgelsbyAJuneauPDurdenE. Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population in the United States. J Occup Environ Med2013; 55: 1262–1270.
3.
ZhuTTamLLiE. Cost-of-illness studies in systemic lupus erythematosus: a systematic review. Arthritis Care Res (Hoboken)2011; 63: 751–760.
4.
BrownEABrintonDGadsdenBKSimpsonKN. Burden of illness and avoidable costs for people hospitalized with systemic lupus erythematosus: impact of inadequate access to primary care, New Orleans, USA: AcademyHealth, 2017.
5.
SlawskyKAFernandesAWFusfeldLManziSGossTF. A structured literature review of the direct costs of adult systemic lupus erythematosus in the US. Arthritis Care Res (Hoboken)2011; 63: 1224–1232.
6.
Pons-EstelGAlarcónGScofieldLReinlibLCooperG. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum2010; 39: 257–268.
7.
FeldmanCBermasBZibitMet al.Designing an intervention for women with systemic lupus erythematosus from medically underserved areas to improve care: a qualitative study. Lupus2013; 22: 52–62.
8.
AndersonADamioGChapmanDPerez-EscamillaR. Differential response to an exclusive breastfeeding peer counseling intervention: the role of ethnicity. J Hum Lact2007; 23: 16–23.
9.
MalchodiCOnckenCDornelasECaramanicaLGregonisECurryS. The effects of peer counseling on smoking cessation and reduction. Obstet Gynecol2003; 101: 504–510.
10.
WoodburyMBotrosMKuhnkeJGreeneJ. Evaluation of a peer-led self-management education programme PEP talk: diabetes, healthy feet and you. Int Wound J2013; 10: 703–711.
11.
Philis-TsimikasAFortmannALleva-OcanaLWalkerCGalloL. Peer-led diabetes education programs in high-risk Mexican Americans improve glycemic control compared with standard approaches: a Project Dulce promotora randomized trial. Diabetes Care2011; 34: 1926–1931.
12.
GoldenbergDPayneLHayesLZeltzerLTsaoJ. Peer mentorship teaches social tools for pain self-management: a case study. J Pain Manag2013; 6: 61–68.
13.
SandhuSVeinotPEmbuldeniyaGet al.Peer-to-peer mentoring for individuals with early inflammatory arthritis: feasibility pilot. BMJ Open2013; 3: e002267.
14.
LorigKChastainRUngEShoorSHolmanH. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum1989; 32: 37–44.
15.
WilliamsEMHyerJMViswanathanRet al.Peer-to-peer mentoring for African American women with lupus: a feasibility pilot. Arthritis Care Res (Hoboken)2018; 70: 908–917.
16.
LorigKSobelDStewartA. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care1999; 37: 5–14.
17.
LorigKHolmanH. Arthritis self-management studies: a twelve-year review. Health Educ Q1993; 20: 17–28.
18.
Arthritis Foundation. The systemic lupus erythematosus self-help course: program guidelines and procedures manual, Atlanta, USA: Arthritis Foundation, 1987.
19.
WilliamsEBrunerLPenfieldMKamenDOatesJ. Stress and depression in relation to functional health behaviors in African American patients with systemic lupus erythematosus. Rheumatology (Sunnyvale)2014; 2014(Suppl 4): 005.
20.
WilliamsEPenfieldMKamenDOatesJ. An intervention to reduce psychosocial and biological indicators of stress in African American lupus patients: the Balancing Lupus Experiences with Stress Strategies study. Open J Prev Med2014; 4: 22–31.
21.
WilliamsEKamenDPenfieldMOatesJ. Stress intervention and disease in African American lupus patients: the Balancing Lupus Experiences with Stress Strategies (BLESS) study. Health (Irvine Calif)2014; 6: 71–79.
22.
McElhoneKAbbottJShelmerdineJet al.Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum2007; 57: 972–979.
23.
HibbardJStockardJMahoneyETuslerM. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res2004; 39(4 Pt 1): 1005–1026.
24.
BaeSKohH-KChangD-KKimM-HPartJ-KKimS-Y. Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus. Lupus2002; 10: 405–409.
25.
WilliamsEMHyerJMViswanathanRet al.Cytokine balance and behavioral intervention; findings from the Peer Approaches to Lupus Self-management (PALS) project. Hum Immunol2017; 78: 574–581.
26.
KroenkeKSpitzerR. The PHQ-9: A new depression and diagnostic severity measure. Psychiat Ann2002; 32: 509–521.
27.
SpitzerRKroenkeKWilliamsJLoeweB. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med2006; 166: 1092–1097.
28.
WhitleyEValverdePWellsKWilliamsLTeschnerTShihYC. Establishing common cost measures to evaluate the economic value of patient navigation programs. Cancer2011; 117(Suppl 15): 3618–3625.
29.
SandersGDNeumannPJBasuAet al.Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA2016; 316: 1093–1103.
30.
PolinderSToetHPannemanMvan BeeckE. Methodological approaches for cost-effectiveness and cost-utility analysis of injury prevention measures, World Health Organization, 2011.
31.
Rotheram-BorusMRichterLvan HeerdenAet al.A cluster randomized controlled trial evaluating the efficacy of peer mentors to support South African women living with HIV and their infants. PLoS One2014; 9: e84867.
32.
JersonBD'UrsoCArnonRet al.Adolescent transplant recipients as peer mentors: a program to improve self-management and health-related quality of life. Pediatr Transplant2013; 17: 612–620.
33.
ThomasRLorenzettiDSpraginsW. Systematic review of mentoring to prevent or reduce tobacco use by adolescents. Acad Pediatr2013; 13: 300–307.
34.
DorgoSRobinsonKBaderJ. The effectiveness of a peer-mentored older adult fitness program on perceived physical, mental, and social function. J Am Acad Nurse Pract2009; 21: 116–122.
35.
EskiciogluPHalasJSenechalMet al.Peer mentoring for type 2 diabetes prevention in first nations children. Pediatrics2014; 133: e1624–e1631.
36.
HeislerMPietteJ. “I help you, and you help me”: facilitated telephone peer support among patients with diabetes. Diabetes Educ2005; 31: 869–879.
37.
KnoxLHuffJGrahamDet al.What peer mentoring adds to already good patient care: implementing the carpeta roja peer mentoring program in a well-resourced health care system. Ann Fam Med2015; 13(Suppl 1): S59–65.
38.
LongJJahnleERichardsonDLoewensteinGVolppK. Peer mentoring and financial incentives to improve glucose control in African American veterans: a randomized trial. Ann Intern Med2012; 156: 416–424.
39.
WilliamsEMEgedeLFaithTOatesJ. Effective self-management interventions for patients with lupus: potential impact of peer mentoring. Am J Med Sci2017; 353: 580–592.
40.
KhamashtaMABruceINGordonCet al.The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease. Lupus2014; 23: 273–283.
41.
OglesbyAKorvesCLaliberteFet al.Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes. Appl Health Econ Health Policy2014; 12: 179–190.
42.
BillingsJAndersonGMNewmanLS. Recent findings on preventable hospitalizations. Health Aff (Millwood)1996; 15: 239–249.
43.
GaskinDJHoffmanC. Racial and ethnic differences in preventable hospitalizations across 10 states. Med Care Res Rev2000; 57(Suppl 1): 85–107.
44.
WardMM. Avoidable hospitalizations in patients with systemic lupus erythematosus. Arthritis Rheum2008; 59: 162–168.
PortnoyJMWallerMDe LurgioSDinakarC. Telemedicine is as effective as in-person visits for patients with asthma. Ann Allergy Asthma Immunol2016; 117: 241–245.
47.
IsettaVNegrinMAMonasterioCet al.A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial. Thorax2015; 70: 1054–1061.
48.
HirshkowitzMSharafkhanehA. A telemedicine program for diagnosis and management of sleep-disordered breathing: the fast-track for sleep apnea tele-sleep program. Semin Respir Crit Care Med2014; 35: 560–570.
49.
HeislerM. Different models to mobilize peer support to improve diabetes self-management and clinical outcomes: evidence, logistics, evaluation considerations and needs for future research. Fam Pract2010; 27(Suppl 1): i23–i32.
50.
LawGPopeJLalaniSet al.Barriers to healthcare in a multiethnic cohort of systemic lupus erythematosus (SLE) patients: patient and physician perceptions. Rom J Rheumatol2010; 19: 12–19.
